Rippling muscle disease and cardiomyopathy associated with a mutation in the CAV3 gene

Neuromuscular Disorders

Volumn 19, Issue 11, 2009, Pages 779-783

  Catteruccia, Michela ^a   Sanna, Tommaso ^a   Santorelli, Filippo Maria ^b   Tessa, Alessandra ^b   Giacopo, Raffaella Di ^a   Sauchelli, Donato ^a   Verbo, Alessandro ^c   Monaco, Mauro Lo ^a   Servidei, Serenella ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Caveolin 3; Dilated cardiomyopathy; Rippling muscle disease

Indexed keywords

CAVEOLIN 3;

ADULT; ARTICLE; ATRIOVENTRICULAR CONDUCTION; AUTOSOMAL DOMINANT INHERITANCE; CARDIOMYOPATHY; CASE REPORT; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MUSCLE BIOPSY; MUSCLE CRAMP; MUSCLE DISEASE; MUSCLE STIFFNESS; NEUROPHYSIOLOGY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RIPPLING MUSCLE DISEASE;

ADULT; ALANINE; CARDIOMYOPATHIES; CAVEOLIN 3; ELECTROCARDIOGRAPHY; ELECTROMYOGRAPHY; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUTATION; VALINE; YOUNG ADULT;

EID: 70350048397     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.08.015     Document Type: Article

References (28)

1. Song K.S., Scherer P.E., Tang Z., et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 21 (1996) 15160-15165
2. Galbiati F., Razani B., and Lisanti M.P. Caveole and caveolin-3 in muscular dystrophy. Trends Mol Med 7 (2001) 435-441
3. Monier S., Parton R.G., Vogel F., Behlke J., Henske A., and Kurzchalia T.V. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol Biol Cell 6 (1995) 911-927
4. Minetti C., Sotgia F., Bruno C., et al. Mutations in the caveolin-3 gene cause autosomal dominant limb girdle muscular dystrophy. Nat Gen 18 (1998) 365-368
5. Betz R.C., Schoser B.G.H., Kasper D., et al. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Gen 28 (2001) 218-219
6. Carbone I., Bruno C., Sotgia F., et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 54 (2000) 1373-1376
7. Tateyama M., Aoki M., Nishino I., et al. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology 58 (2002) 323-325
8. Hayashi T., Arimura T., Ueda K., et al. Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy. Biochem Biophys Res Commun 313 (2004) 178-184
9. Vatta M., Ackerman M.J., Ye B., et al. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 114 (2006) 2104-2112
10. Cronk L.B., Ye B., Kaku T., et al. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm 4 (2007) 161-166
11. Traverso M., Bruno C., Broccolini A., et al. Truncation of caveolin-3 causes autosomal-recessive rippling muscle disease. J Neurol Neurosurg Psychiatry 79 (2008) 735-737
12. Fischer D., Schroers A., Blümcke I., et al. Consequences of a novel caveolin-3 mutation in a large German family. Ann Neurol 53 (2003) 233-241
13. Müller J.S., Piko H., Schoser B.G.H., et al. Novel splice site mutation in the caveolin-3 gene leading to autosomal recessive limb girdle muscular dystrophy. Neuromuscul Disord 16 (2006) 432-436
14. Woodman S.E., Park D.S., Cohen A.W., et al. Caveolin-3 knock out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 277 (2002) 38988-38997
15. Ohsawa Y., Toko H., Katsura M., et al. Over-expression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity. Hum Mol Genet 13 (2004) 151-157
16. Feron O., Belhassen L., Kobzik L., Smith T.W., Kelly R.A., and Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271 (1996) 22810-22814
17. Kobzik L., Reid M.B., Bredt D.S., and Stamler J.S. Nitric oxide in skeletal muscle. Nature 372 (1994) 546-548
18. Venema V.J., Ju H., Zou R., and Venema R.C. Interaction of neuronal nitric oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 272 (1997) 28187-28190
19. Scherer P.E., and Lisanti M.P. Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes: dynamic regulation by extracellular glucose and intracellular metabolites. J Biol Chem 272 (1997) 20698-20705
20. Head B.P., Patel H.H., Roth D.M., et al. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem 280 (2005) 31036-31044
21. Wyse B.D., Prior I.A., Qian H., et al. Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane. J Biol Chem 278 (2003) 23738-23746
22. Koga A., Oka N., Kikuchi T., Miyazaki H., Kato S., and Imaizumi T. Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy. Hypertension 42 (2003) 213-219
23. Traverso M., Gazzerro E., Asseret S., et al. Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro. Lab Invest 8 (2008) 275-278
24. McCrohon J.A., Moon J.C., Prasad S.K., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108 (2003) 54-59
25. Assomull R.G., Prasad S.K., Lyne J., et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48 10 (2006) 1977-1985
26. Balijepalli R.C., and Kamp T.J. Caveolae, ion channels and cardiac arrhythmias. Prog Biophys Mol Biol 98 (2008) 149-160
27. Fulizio L., Nascimbeni A.C., Fanin M., et al. Molecular and muscle pathology in a series of caveolinopathy patients. Hum Mutat 25 (2005) 82-89
28. Ricker K., Moxley R.T., and Rohkamm R. Rippling muscle disease. Arch Neurol 46 (1989) 405-408